î
îž
î
Qiagen NV
QGEN48.560USD
+1.340+2.84%
āļāļīāļÂ 11/25, 16:00ïžETïžāļĢāļēāļāļēāļĨāđāļēāļāđāļē 15 āļāļēāļāļĩ
10.53BāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
25.98P/E TTM
î
āļĢāļēāļĒāļĨāļ°āđāļāļĩāļĒāļāđāļāļīāđāļĄāđāļāļīāļĄāļāļāļ Qiagen NV āļāļĢāļīāļĐāļąāļ
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
āļāđāļāļĄāļđāļĨ Qiagen NV
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļQGEN
āļāļ·āđāļāļāļĢāļīāļĐāļąāļQiagen NV
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 01, 1996
āļāļĩāļāļĩāđāļMr. Thierry Bernard
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ5765
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļSep 01
āļāļĩāđāļāļĒāļđāđHulsterweg 82
āđāļĄāļ·āļāļVENLO
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻNetherlands
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ5912 PL
āđāļāļĢāļĻāļąāļāļāđ31773556600
āđāļ§āđāļāđāļāļāđhttps://www.qiagen.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļQGEN
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 01, 1996
āļāļĩāļāļĩāđāļMr. Thierry Bernard
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ Qiagen NV
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
āļŠāļąāļāļŠāđāļ§āļāļāļāļāļĢāļēāļĒāđāļāđ
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 6 āļ.āļ.
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 6 āļ.āļ.
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
United States
260.49M
48.82%
Europe & Middle East & Africa
179.30M
33.61%
Asia, Pacific & Rest of the World
73.46M
13.77%
Other Americas
20.29M
3.80%
āļāļēāļĄāļāļļāļĢāļāļīāļ
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļ
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Consumables and Related Revenues
476.33M
89.28%
Instrumentation
57.21M
10.72%
āļŠāļāļīāļāļīāļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 17 āļ.āļĒ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 17 āļ.āļĒ.
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
Wellington Management Company, LLP
10.76%
MFS Investment Management
10.56%
The Vanguard Group, Inc.
4.30%
T. Rowe Price International Ltd
3.47%
DWS Investment GmbH
2.13%
āļāļ·āđāļ āđ
68.78%
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
Wellington Management Company, LLP
10.76%
MFS Investment Management
10.56%
The Vanguard Group, Inc.
4.30%
T. Rowe Price International Ltd
3.47%
DWS Investment GmbH
2.13%
āļāļ·āđāļ āđ
68.78%
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
Investment Advisor/Hedge Fund
48.71%
Investment Advisor
25.43%
Research Firm
5.08%
Pension Fund
1.63%
Sovereign Wealth Fund
1.60%
Hedge Fund
1.10%
Bank and Trust
1.09%
Individual Investor
0.44%
Insurance Company
0.05%
āļāļ·āđāļ āđ
14.86%
āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļļāļāļāļĩāđ 1 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļļāļāļāļĩāđ 1 āļ.āļ.
āļāđāļ§āļāđāļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļāļēāļ
āļāļģāļāļ§āļāļŠāļāļēāļāļąāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
2025Q3
996
177.81M
82.00%
-32.33M
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļīāļāļāļĢāļĢāļĄāļāļđāđāļāļ·āļāļŦāļļāđāļ
îāļāļ·āđāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
āđāļāļĨāļĩāđāļĒāļ%
āļ§āļąāļāļāļĩāđ
Wellington Management Company, LLP
26.02M
12%
+1.59M
+6.49%
Jun 30, 2025
MFS Investment Management
23.48M
10.83%
-787.04K
-3.24%
Jun 30, 2025
The Vanguard Group, Inc.
9.16M
4.22%
+372.54K
+4.24%
Jun 30, 2025
T. Rowe Price International Ltd
5.94M
2.74%
+1.79M
+43.10%
Jun 30, 2025
DWS Investment GmbH
3.30M
1.52%
+2.74M
+482.72%
Jun 30, 2025
EARNEST Partners, LLC
4.20M
1.94%
+395.58K
+10.39%
Jun 30, 2025
Amundi Asset Management, SAS
3.98M
1.83%
-217.72K
-5.19%
Jun 30, 2025
Boston Partners
2.36M
1.09%
+13.48K
+0.58%
Aug 31, 2025
BlackRock Institutional Trust Company, N.A.
20.54M
9.47%
+174.28K
+0.86%
Sep 10, 2025
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
ETF āļāļĩāđāđāļāļĩāđāļĒāļ§āļāđāļāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļĪāļŦāļąāļŠāļāļĩāđ 6 āļ.āļĒ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļĪāļŦāļąāļŠāļāļĩāđ 6 āļ.āļĒ.
āļāļ·āđāļ
āļŠāļąāļāļŠāđāļ§āļ
First Trust Nasdaq Lux Digi Health Solutions ETF
3.85%
Global X Genomics & Biotechnology ETF
3.76%
Invesco Biotechnology & Genome ETF
2.45%
VanEck Biotech ETF
1.81%
ROBO Global Healthcare Technology & Innovation ETF
1.46%
Pacer US Large Cap Cash Cows Growth Leaders ETF
1.18%
Franklin Genomic Advancements ETF
1%
iShares Health Innovation Active ETF
0.93%
Burney US Factor Rotation ETF
0.75%
WisdomTree International Multifactor Fund
0.68%
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļāļŠāđāļ§āļ3.85%
Global X Genomics & Biotechnology ETF
āļŠāļąāļāļŠāđāļ§āļ3.76%
Invesco Biotechnology & Genome ETF
āļŠāļąāļāļŠāđāļ§āļ2.45%
VanEck Biotech ETF
āļŠāļąāļāļŠāđāļ§āļ1.81%
ROBO Global Healthcare Technology & Innovation ETF
āļŠāļąāļāļŠāđāļ§āļ1.46%
Pacer US Large Cap Cash Cows Growth Leaders ETF
āļŠāļąāļāļŠāđāļ§āļ1.18%
Franklin Genomic Advancements ETF
āļŠāļąāļāļŠāđāļ§āļ1%
iShares Health Innovation Active ETF
āļŠāļąāļāļŠāđāļ§āļ0.93%
Burney US Factor Rotation ETF
āļŠāļąāļāļŠāđāļ§āļ0.75%
WisdomTree International Multifactor Fund
āļŠāļąāļāļŠāđāļ§āļ0.68%
āđāļāļīāļāļāļąāļāļāļĨ
îāļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
āļ§āļąāļāļāļĩāđ
āđāļāļīāļāļāļąāļāļāļĨ
āļ§āļąāļāļāļĩāđāļāļąāļāļāļķāļ
āļ§āļąāļāļāļĩāđāļāļģāļĢāļ°āđāļāļīāļ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
āļāļēāļĢāđāļāđāļāļŦāļļāđāļ
îāļ§āļąāļāļāļĩāđ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
Jan 17, 2025
Merger
36â35
Jan 17, 2025
Merger
36â35
Jan 17, 2025
Merger
36â35
Jan 17, 2025
Merger
36â35
Jan 18, 2024
Merger
25â24.25
Jan 18, 2024
Merger
25â24.25
āļ§āļąāļāļāļĩāđ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
Jan 17, 2025
Merger
36â35
Jan 17, 2025
Merger
36â35
Jan 17, 2025
Merger
36â35
Jan 17, 2025
Merger
36â35
Jan 18, 2024
Merger
25â24.25
Jan 18, 2024
Merger
25â24.25
Jan 18, 2024
Merger
25â24.25
Jan 18, 2024
Merger
25â24.25
āļāļģāļāļēāļĄāļāļĩāđāļāļāļāđāļāļĒ
āđāļāļĢāļāļ·āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Qiagen NV?
îāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Qiagen NV āđāļāđāđāļāđ:
Wellington Management Company, LLP āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 26.02M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 12.00% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
MFS Investment Management āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 23.48M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 10.83% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
The Vanguard Group, Inc. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 9.16M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 4.22% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
T. Rowe Price International Ltd āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 5.94M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.74% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
DWS Investment GmbH āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 3.30M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 1.52% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
Wellington Management Company, LLP āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 26.02M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 12.00% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
MFS Investment Management āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 23.48M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 10.83% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
The Vanguard Group, Inc. āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 9.16M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 4.22% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
T. Rowe Price International Ltd āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 5.94M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 2.74% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
DWS Investment GmbH āļāļ·āļāļāļĢāļāļāļŦāļļāđāļāļāļģāļāļ§āļ 3.30M āļŦāļļāđāļ āļāļīāļāđāļāđāļ 1.52% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŠāļēāļĄāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Qiagen NV āļāļ·āļāļāļ°āđāļĢ?
îāļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŠāļēāļĄāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Qiagen NV āđāļāđāđāļāđ
Wellington Management Company, LLP
MFS Investment Management
The Vanguard Group, Inc.
Wellington Management Company, LLP
MFS Investment Management
The Vanguard Group, Inc.
āļĄāļĩāļāļĩāđāļŠāļāļēāļāļąāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ Qiagen NV (QGEN)?
îāļ āļ§āļąāļāļāļĩāđ 2025Q3 āļĄāļĩāļŠāļāļēāļāļąāļāļāļģāļāļ§āļ 996 āđāļŦāđāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ Qiagen NV āđāļāļĒāļĄāļĩāļĄāļđāļĨāļāđāļēāļĢāļ§āļĄāļāļĢāļ°āļĄāļēāļ 177.81M āļāļīāļāđāļāđāļ 82.00% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ āđāļĄāļ·āđāļāđāļāļĩāļĒāļāļāļąāļāļ§āļąāļāļāļĩāđ 2025Q2 āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļāđāļāđāđāļāļīāđāļĄāļāļķāđāļ -5.53%
āđāļŦāļĨāđāļāļĢāļēāļĒāđāļāđāļŦāļĨāļąāļāļāļāļ Qiagen NV āļāļ·āļāļāļ°āđāļĢ?
îāđāļĄāļ·āđāļāļ§āļąāļāļāļĩāđ FY2025Q2 āļāļļāļĢāļāļīāļāļāđāļēāļ Consumables and Related Revenues āļŠāļĢāđāļēāļāļĢāļēāļĒāđāļāđāļŠāļđāļāļŠāļļāļāđāļŦāđāļāļąāļ Qiagen NV āļāļīāļāđāļāđāļāļĄāļđāļĨāļāđāļē 476.33M āđāļĨāļ°āļāļīāļāđāļāđāļ 89.28% āļāļāļāļĢāļēāļĒāđāļāđāļĢāļ§āļĄ
